Board Candidate
Duke Pitts
Public-Company Director · Audit · Governance · M&A
Turning Business Challenges Into Opportunities™.
Board Value Proposition
Operator-director with lived P&L accountability at a public issuer and 25+ years leading scale-ups, turnarounds, and M&A integrations. I am a problem solver at heart, focused on turning business challenges into opportunities. I bring boards a rare combination: capital-markets fluency (OTCQB, SEC reporting, uplist readiness), FDA / OTC cGMP regulatory depth, and the commercial instinct to pressure-test management plans against real operating economics. My contribution extends well beyond attendance — I help boards sharpen strategy, tighten governance, and translate ambition into execution.
Areas of Board Contribution
- Capital markets, IPO / uplist readiness
- SEC reporting, OTCQB & FINRA interfaces
- Audit committee — controls, KPI transparency
- M&A strategy, diligence, and post-close integration
- FDA / OTC cGMP regulatory oversight
- Executive compensation & CEO succession
- Enterprise risk, cyber, and quality assurance
- Investor relations & public communications
- Commercial & manufacturing strategy review
- Founder-CEO coaching and organizational design
Current & Prior Board Service
Healthy Extracts Inc. (OTCQB: HYEX) — healthyextractsinc.com
2019 — Jul 2026Board Member · President · Chief Operating Officer
- Served as a director of a publicly traded nutraceutical platform (2019 – July 2026); contributed to strategy, capital allocation, M&A approval, and governance oversight.
- Partnered with the board on four completed acquisitions — sourcing, valuation, structuring, and integration governance (BergametNA, UBN, Gummy USA, Imarais Beauty).
- Championed uplist readiness: audit discipline, board reporting cadence, KPI dashboards, and shareholder communications.
- Directed FDA and OTC cGMP compliance oversight, including FDA Pharma approval pathways.
- Guided debt restructuring and turnaround to a $1M swing and cash-positive operations.
Executive Experience Informing Board Judgment
DT Growth Partners LLC
2016 — PresentFounder & Managing Partner
- Advise founders, CEOs, and boards on capital formation, M&A, operational excellence, commercialization, manufacturing strategy, and public-company readiness.
- Four private companies founded and successfully exited — full lifecycle judgment from formation through sale.
Pitts-Dunahay, Inc. dba Envision Enterprises
2007 — 2020Founder · President & Chief Operating Officer
- Founded, scaled, and exited a premier smart-home and commercial AV integration firm; Control4 Platinum Dealer; sold in 2020.
- Owned P&L, vendor negotiation, and multi-site operating discipline.
EchoStar / DISH Network
1998 — 2007Director of Marketing
- Led a $35M direct-marketing organization; built competitive intelligence and segmentation infrastructure acquiring hundreds of thousands of subscribers.
- Directed retail merchandising across 7,000+ locations.
Governance & Regulatory Credentials
- Active public-company board service (OTCQB issuer) since 2019.
- SEC reporting, Sarbanes-Oxley-aligned controls, and OTCQB disclosure discipline.
- FDA and OTC cGMP oversight, including FDA Pharma approval pathways.
- M&A governance across four completed acquisitions — LOI to Day-100.
- Investor relations and public communications leadership.
- Capital formation, PIPE / equity raises, and shareholder-value initiatives.
Committee Fit
- Audit — operator familiarity with SEC / OTCQB reporting, KPI transparency, and internal controls.
- Nominating & Governance — board composition, charter design, and public-company disclosure hygiene.
- Compensation — equity plan design, CEO / CFO scorecards, and pay-for-performance alignment.
- Strategy / M&A — sourcing, diligence, integration, and post-close value capture.
Sector Coverage
Nutraceuticals & Functional Nutrition · Pharmaceuticals · Consumer Products · Contract Manufacturing / Private Label · Consumer Electronics & Smart Home · Subscription Services · E-commerce Marketplaces (Amazon) · Retail
Availability & Independence
Available for one to two additional public or private board seats. Willing to serve on audit, compensation, nominating / governance, or strategy / M&A committees. No conflicting fiduciary duties in the nutraceutical, consumer-products, or capital-markets advisory verticals beyond disclosed engagements.
References
Provided on request. Available for reference calls with nominating committees.